Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.49 |
| ▸ | HTT | P42858 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1500498 | 0.98 | LMNA (0.48) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL12759075 | 0.98 | LMNA (0.46) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL6268570 | 0.85 | LMNA (0.64) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL21423060 | 0.85 | LMNA (0.64) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL1500496 | 0.84 | LMNA (0.45) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL9326230 | 0.83 | LMNA (0.62) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL27551258 | 0.83 | LMNA (0.62) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL14537256 | 0.83 | LMNA (0.61) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL29219505 | 0.83 | LMNA (0.50) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL16000715 | 0.83 | LMNA (0.50) | LMNAHTTSMN1; SMN2APOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242760-B1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-03-05 | — | — | EP | disclosed |
| EP-2242760-B1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2242760-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | Dow Global Technologies Inc. (US) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009091669-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | ORMDL3, IP6K3, ALK | LMNA 4629/4885HTT 4445/4885SMN1; SMN2 3694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.